Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

4 treatments under study, led by Soc Neurological Care

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

33.3%

1 terminated out of 3 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 1 (1)
Phase 3 (1)

Trial Status

Completed1
Terminated1
Active Not Recruiting1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05353452Not ApplicableCompletedPrimary

Collaborative Care in Posttraumatic Epilepsy

NCT03999164Phase 1Active Not RecruitingPrimary

Imaging of Neuro-Inflammation and the Risk for Post-Traumatic Epilepsy

NCT00566046Phase 3TerminatedPrimary

Prevention of Post-traumatic Seizures With Levetiracetam

Showing all 3 trials

Research Network

Common Treatments

  • Soc Neurological Care1
  • 18fdpa714 Positron Emission Tomography Scan1
  • Levetiracetam1
  • Neurology Based Collaborative Care1

Active Sponsors

  • Rennes University Hospital1
  • Wake Forest University Health Sciences1
  • University of California, Davis1
  • UCB Pharma1

Top Investigators

Activity Timeline